CATALOGO DEI PRODOTTI DELLA RICERCA

CASTAGNA, Annalisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.819
EU - Europa 3.117
AS - Asia 1.514
SA - Sud America 17
AF - Africa 13
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.490
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.809
GB - Regno Unito 978
CN - Cina 918
SG - Singapore 409
DE - Germania 350
SE - Svezia 339
IT - Italia 288
RU - Federazione Russa 278
FR - Francia 265
IE - Irlanda 255
FI - Finlandia 192
UA - Ucraina 66
JP - Giappone 61
BE - Belgio 40
VN - Vietnam 36
KR - Corea 15
IN - India 14
TR - Turchia 14
ID - Indonesia 12
NL - Olanda 12
AU - Australia 9
CA - Canada 9
CL - Cile 9
HK - Hong Kong 8
CH - Svizzera 7
IR - Iran 7
TG - Togo 6
GR - Grecia 5
IL - Israele 5
CZ - Repubblica Ceca 4
EE - Estonia 4
EG - Egitto 4
ES - Italia 4
PT - Portogallo 4
AT - Austria 3
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
PK - Pakistan 3
AR - Argentina 2
BG - Bulgaria 2
BR - Brasile 2
DK - Danimarca 2
EC - Ecuador 2
LV - Lettonia 2
NO - Norvegia 2
PL - Polonia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BO - Bolivia 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EU - Europa 1
IS - Islanda 1
KE - Kenya 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
MU - Mauritius 1
PH - Filippine 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
ZA - Sudafrica 1
Totale 8.490
Salva come PNG Salva come JPEG
Città #
Southend 856
Chandler 741
Jacksonville 505
Ann Arbor 359
Singapore 337
Woodbridge 307
Dublin 255
Ashburn 205
Houston 203
Beijing 159
New York 132
Wilmington 119
Verona 110
Lawrence 102
Princeton 102
Jinan 81
Nanjing 77
Boardman 76
Shenyang 69
Tokyo 60
Helsinki 54
Hebei 42
Brussels 40
Redmond 35
Sindelfingen 34
Lancaster 33
Tianjin 30
Zhengzhou 30
Changsha 29
Haikou 29
Nanchang 29
Jiaxing 24
Milan 23
Santa Clara 23
Munich 22
Dong Ket 20
Hangzhou 20
Taiyuan 20
Seattle 19
Guangzhou 18
Ningbo 17
Taizhou 17
Padova 16
Falls Church 15
Norwalk 15
Nürnberg 14
Fuzhou 13
Los Angeles 13
Seoul 13
Fairfield 12
Jakarta 12
Boydton 11
Dearborn 11
Redwood City 11
Washington 10
Bologna 9
Dallas 9
Düsseldorf 9
Lanzhou 9
San Mateo 7
Toronto 7
Zurich 7
Auburn Hills 6
Lomé 6
San Francisco 6
Trento 6
Ardabil 5
Clearwater 5
Kent 5
London 5
Meppel 5
Shanghai 5
Bussolengo 4
Catanzaro 4
Hong Kong 4
Las Vegas 4
Ospedaletto Euganeo 4
Riva 4
San Giovanni Lupatoto 4
Athens 3
Bangalore 3
Bishkek 3
Borgo Valsugana 3
Budapest 3
Cambridge 3
Canberra 3
Fermo 3
Frankfurt am Main 3
Groningen 3
Kharkov 3
Kochi 3
Madison 3
Moscow 3
San Diego 3
Tallinn 3
Tappahannock 3
Tomsk 3
Vienna 3
Zagreb 3
Amsterdam 2
Totale 5.830
Salva come PNG Salva come JPEG
Nome #
Increased urinary excretion of the epithelial Na channel activator prostasin in patients with primary aldosteronism 239
Urinary prostasin in normotensive individuals: correlation with the aldosterone to renin ratio and urinary sodium. 135
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. 126
The proteome: anno Domini 2002 118
Urinary protease inhibitor Serpin B3 is higher in women and is further increased in female patients affected by aldosterone producing adenoma 112
Tarrgeted Exome Sequencing of 5 Hemochromatosis Genes in Iron Overloaded Patients by Next Generation Sequencing (NGS) Platform. 110
Apolipoprotein -CIII glycoforms correlate heterogeneously with plasma lipid profile in subjects with coronary artery disease 110
miRNAs purification and analysis from urinary exosomes. 108
Serum levels of the hepcidin-20 isoform in a large general population: The Val Borbera study. 107
Immunoaffinity reactors for prion protein qualitative analysis 106
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study 105
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 103
Identification of new BMP6 pro-peptide mutations in patients with iron overload 103
ApoCIII glycoforms determination and proteomic analysis in plasma of coronary patients with different ApoCIII levels . 102
Hepcidin and DNA promoter methylation in hepatocellular carcinoma 99
Comparative two-dimensional mapping of prion protein isoforms in human cerebrospinal fluid and central nervous system 98
“Proteome analysis in the clinical chemistry laboratory: myth or reality?” 98
"Exploring the hidden human urinary proteome via ligand library beads" 98
Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin 98
HEPCIDIN REPRESSION BY PROMOTER DNA HYPERMETHYLATION IN NON-VIRAL HEPATOCELLULAR CARCINOMA 98
pH-dependent prion protein conformation in classical Creutzfeldt-Jakob disease 98
Isoelectric beads for proteome pre-fractionation.II :experimental evaluation in a multicompartment electroyzer 96
Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism 96
Hepcidin Inhibition by Modified Heparins without Anticoagulant Activity 96
“Proteomics approaches for studying chemoresistance in cancer” 95
Altered paraoxonase expression in patients with genetic haemochromatosis. 95
Altered iron parameters and hepcidin levels in a general population: lesson from the CHRIS study 95
“Critical survey of quantitative proteomics in two-dimensional electrophoretic approaches” 94
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 93
Amphoteric,buffering chromatographic beads for proteome prefractionation.I :theoretical model 92
Monocyte/macrophage proteomics: recent findings and biomedical applications. 92
Murine macrophages response to iron 91
Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS 91
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. 90
Urinary prostasin: a candidate marker of ENaC activation in humans:study of preliminary feasibility 89
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 89
NT-proBNP, a useful tool in hypertensive patients undergoing a diagnostic evaluation for primary aldosteronism. 89
“Conventional isoelectric focusing in gel slabs and capillaries and immobilized pH gradients” 88
Epigenetic control of 11-beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension 87
Iron metabolism in Murine Macrophages: a proteomic insight. 87
How to bring the "unseen" proteome to the limelight via electrophoretic pre-fractionation techniques 87
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 86
Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents 84
Plasma proteomic analysis of patients with Coronary Artery Disease with different levels of apolipoprotein CIII 84
Female urinary proteomics: New insight into exogenous and physiological hormone-dependent changes. 83
A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431. 82
Prefractionation techniques in proteome analysis: the mining tools of the third millennium. 82
Epigenetics regulation of HSD11B2 gene by promoter methylation in glucocorticoid-treated patients 82
Aceruloplasminemia: A Severe Neurodegenerative Disorder Deserving an Early Diagnosis 82
A single dialysis session of hemodiafiltration with sorbent-regenerated endogenous ultrafiltrate reinfusion (HFR) removes hepcidin more efficiently than bicarbonate hemodialysis: a new approach to containing hepcidin burden in dialysis patients? 81
Surface plasmon resonance based on molecularly imprinted nanoparticles for the picomolar detection of the iron regulating hormone Hepcidin-25 80
Apolipoprotein C-III glycoforms correlate heterogeneously with plasma lipid profile in subjects with coronary artery disease 80
Carbamylation of proteins in 2-D electrophoresis--myth or reality? 79
Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation 79
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. 77
High resolution preparation of monocyte-derived macrophages (MDM) protein fractions for clinical proteomics 77
Reduced serum hepcidin levels in patients with chronic hepatitis C 77
Myristic acid plasma levels are strongly correlated with triglyceride and Apolipoprotein C-III plasma concentration in a cohort of subjects with or without coronary artery disease 77
Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up 77
Imprinted polymers for the recognition/quantitation of the peptide hormone hepcidin 76
Prefractionation techniques in proteome analysis. 75
Increased plasma thrombin potential is associated with stable coronary artery disease: An angiographically-controlled study 75
Not Just Arterial Damage: Increased Incidence of Venous Thromboembolic Events in Cardiovascular Patients With Elevated Plasma Levels of Apolipoprotein CIII 75
Complement activation in the plasma and placentas of women with different subsets of antiphospholipid syndrome 75
Beta-elimination: an unexpected artefact in proteome analysis. 73
Prefractionation techniques in proteome analysis. 71
Optimizing the purification and analysis of miRNAs from urinary exosomes. 71
The role of TMPRSS6 and HFE variants in iron deficiency anemia in celiac disease 71
Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy 71
Epigenetic control of hydroxysteroid (11-beta) dehydrogenase 2 gene is related to human hypertension 70
"Prefractionation of urinary proteins" 70
Myristic acid induces proteomic and secretomic changes associated with steatosis, cytoskeleton remodeling, endoplasmic reticulum stress, protein turnover and exosome release in HepG2 cells 70
Reducing protein concentration range of biological samples using solid-phase ligand libraries 69
Increased Incidence of Ischemic Cerebrovascular Events in Cardiovascular Patients With Elevated Apolipoprotein CIII 69
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 68
Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism 68
Serum Uric Acid Levels, but Not rs7442295 Polymorphism of SCL2A9 Gene, Predict Mortality in Clinically Stable Coronary Artery Disease 67
Modern iron replacement therapy: clinical and pathophysiological insights 65
Provisional standardization of hepcidin assays: creating a traceability chain with a primary reference material, candidate reference method and a commutable secondary reference material 65
Detection of urinary exosomal HSD11B2 mRNA expression: a useful novel tool for the diagnostic approach of dysfunctional 11β-HSD2-related hypertension 64
”SPR biosensors and “natural hepcidin receptor” immobilization for hepcidin-25 determination in serum.” 62
Hormone-Dependent Changes in Female Urinary Proteome 61
Plasma Proteome Profiles of Stable CAD Patients Stratified According to Total Apo C-III Levels 61
Hepcidin assay in serum by SELDI-TOF-MS and other approaches 60
Trace Elements Status and Metallothioneins DNA Methylation Influence Human Hepatocellular Carcinoma Survival Rate 60
Hepcidin resistance in dysmetabolic iron overload 59
High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis 58
Measurament of urinary hepcidin levels by self-tof-ms in HFE-hemochromatosis 58
Urinary Metabolic Signature of Primary Aldosteronism: Gender and Subtype-Specific Alterations 58
Recent trends in proteome analysis. 56
HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients. 56
Aptamer-modified FXa generation assays to investigate hypercoagulability in plasma from patients with ischemic heart disease 56
A Novel ALAS2 Missense Mutation in Two Brothers With Iron Overload and Associated Alterations in Serum Hepcidin/Erythroferrone Levels 53
Sucrosomial® Iron Supplementation in Mice: Effects on Blood Parameters, Hepcidin, and Inflammation 52
Basophil Blood Cell Count Is Associated With Enhanced Factor II Plasma Coagulant Activity and Increased Risk of Mortality in Patients With Stable Coronary Artery Disease: Not Only Neutrophils as Prognostic Marker in Ischemic Heart Disease 52
Sialylated isoforms of apolipoprotein C-III and plasma lipids in subjects with coronary artery disease 50
High Plasma Concentration of Apolipoprotein C-III Confers an Increased Risk of Cerebral Ischemic Events on Cardiovascular Patients Anticoagulated With Warfarin 49
Impact of natural Neuromedin-B receptor variants on iron metabolism 46
Treatment options for anemia in the elderly 45
null 44
Totale 8.226
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.439
article - articoli 24.037
book - libri 0
conference - conferenze 6.615
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 787
Totale 62.878
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020693 0 0 0 0 103 107 116 67 57 110 41 92
2020/2021839 61 122 64 107 109 89 25 53 45 25 91 48
2021/2022812 62 256 8 63 25 25 7 37 43 18 75 193
2022/20232.027 120 231 167 335 199 474 31 127 261 12 36 34
2023/20241.075 43 88 72 106 117 209 21 69 12 29 189 120
2024/2025942 125 183 123 427 84 0 0 0 0 0 0 0
Totale 8.617